Charité Campus Mitte, Institute of Pathology, D-10117 Berlin, Germany.
Anticancer Res. 2010 Feb;30(2):629-33.
The multifunctional Y-Box protein 1 (YB-1) exerts positive and negative regulatory effects on gene expression by different mechanisms. Since transcription can be controlled by micro RNAs (miRNAs), YB-1 could also cause effects on gene expression by regulation of cellular miRNAs. To test this hypothesis, a previously established and well-characterized cell model derived from drug-sensitive (EPG85-257P/tetR/YB-1) and multidrug-resistant (EPG85-257RDB/tetR/YB-1) gastric carcinoma cells, in which the expression of YB-1 can be inhibited by tetracycline-dependent triggering of the RNA interference (RNAi) pathway, was investigated concerning their miRNA expression profiles in the presence and absence of YB-1. Microarray hybridizations demonstrated that six miRNAs (miR-96*, miR-210, miR-503, miR-623, miR-1275, miR-1290) were up-regulated more than 1.5-fold in drug-sensitive cells following YB-1 inhibition, but no differences in miRNA expression could be detected in multidrug-resistant cells. Independent validation of these findings by quantitative real-time reverse transcriptase polymerase chain reaction did not confirm these effects. Likewise, an in silico analysis of potential regulatory effects of the miRNAs on their target genes did not support the potential miRNA regulatory effects of YB-1. In conclusion, the data provide evidence that YB-1 has no direct influence on global miRNA expression pattern in different variants of gastric carcinoma cells and, therewith, does not control gene expression by regulation of miRNAs.
多功能 Y 盒蛋白 1(YB-1)通过不同的机制对基因表达产生正向和负向调节作用。由于转录可以被 microRNAs(miRNAs)控制,因此 YB-1 也可以通过调节细胞内的 miRNAs 来对基因表达产生影响。为了验证这一假设,我们利用之前建立的、特征良好的细胞模型进行了研究,该模型源自对药物敏感(EPG85-257P/tetR/YB-1)和多药耐药(EPG85-257RDB/tetR/YB-1)胃癌细胞,其中 YB-1 的表达可以通过四环素依赖性触发 RNA 干扰(RNAi)途径来抑制。在存在和不存在 YB-1 的情况下,研究了这些细胞的 miRNA 表达谱。微阵列杂交表明,在抑制 YB-1 后,药物敏感细胞中有 6 个 miRNAs(miR-96*、miR-210、miR-503、miR-623、miR-1275、miR-1290)的表达上调了 1.5 倍以上,但在多药耐药细胞中没有检测到 miRNA 表达的差异。通过定量实时逆转录聚合酶链反应对这些发现进行的独立验证并未证实这些影响。同样,对潜在调节作用的计算分析 miRNA 对其靶基因也不支持 YB-1 对 miRNA 的潜在调节作用。总之,这些数据表明 YB-1 对不同胃癌细胞变体的全局 miRNA 表达模式没有直接影响,因此不会通过调节 miRNAs 来控制基因表达。